Centenial Surgical Suture

134.50
+9.50
(7.60%)
Market Cap
49.07 Cr
EPS
3.11
PE Ratio
49.19
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
169.50
52 Week Low
82.15
PB Ratio
1.48
Debt to Equity
0.52
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,393.50
#1 24,252.31
74.60
#1 1,434.50
24.59
#1 258
#1 31.08
61.57
395.30
2,103.24
71.13
307.90
-0.45
43
-46.46
66.87
526.00
631.40
36.20
59.30
30.58
16
25.00
62.97
248.16
248.16
-
102.40
-13.51
-2
-1,500.00
60.69
245.00
131.13
79.33
17.80
#1 136.23
2
-98.33
61.41
105.50
110.17
#1 11.35
109.90
-1.43
10
-
51.40
134.50
#7 49.07
#4 49.19
#7 51.30
#9 -2.84
#7 1
#8 -400.00
64.43
125.00
41.30
82.78
14.00
27.27
1
-
84.07
45.90
39.70
20.77
32.30
14.13
3
0.50
52.47
72.39
36.53
-
89.80
17.54
-3
-35.71
52.81
Growth Rate
Revenue Growth
-2.84 %
Net Income Growth
22.22 %
Cash Flow Change
377.69 %
ROE
23.51 %
ROCE
-3.58 %
EBITDA Margin (Avg.)
19.19 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
52
52
53
53
56
56
37
45
53
51
52
Expenses
47
47
48
48
51
50
32
40
48
46
47
EBITDA
5
5
5
5
5
6
5
5
4
5
6
Operating Profit %
10 %
9 %
9 %
8 %
9 %
10 %
14 %
10 %
8 %
10 %
11 %
Depreciation
1
1
1
1
1
2
2
2
1
1
3
Interest
2
2
2
1
2
2
2
2
2
3
2
Profit Before Tax
3
2
3
2
3
2
2
1
2
1
-0
Tax
1
1
1
1
1
1
1
0
1
0
0
Net Profit
2
2
2
2
2
1
1
1
1
1
-0
EPS in ₹
5.25
4.28
4.71
4.23
5.53
3.55
2.64
1.72
2.43
3.11
-0.60

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
55
53
56
55
57
69
70
61
66
79
Fixed Assets
4
4
4
4
4
10
9
8
7
13
Current Assets
51
49
52
51
52
58
61
53
59
65
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
51
49
52
51
53
59
61
54
60
66
Total Liabilities
55
53
56
55
57
69
70
61
66
79
Current Liabilities
31
27
28
27
26
31
32
24
29
33
Non Current Liabilities
3
3
3
3
3
10
9
7
6
14
Total Equity
21
23
25
26
28
29
30
30
31
32
Reserve & Surplus
16
17
19
21
23
23
24
25
26
27
Share Capital
5
5
5
5
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-1
-0
0
-1
0
-0
-0
0
0
Investing Activities
-0
-0
-2
-1
-1
-1
-1
-0
-0
-8
Operating Activities
0
-2
0
2
2
2
2
5
1
6
Financing Activities
1
1
2
-1
-1
-0
-1
-5
-1
2

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
44.78 %
44.78 %
44.78 %
44.78 %
44.78 %
44.78 %
44.78 %
44.78 %
45.48 %
46.89 %
46.89 %
46.89 %
46.89 %
46.89 %
46.89 %
46.89 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
53.35 %
53.24 %
53.25 %
53.24 %
53.33 %
53.31 %
53.31 %
53.29 %
52.33 %
51.86 %
51.95 %
51.71 %
51.68 %
50.21 %
50.21 %
50.20 %
Others
1.86 %
1.97 %
1.96 %
1.98 %
1.89 %
1.91 %
1.91 %
1.92 %
2.19 %
1.25 %
1.16 %
1.40 %
1.43 %
2.90 %
2.90 %
2.91 %
No of Share Holders
700
790
799
867
887
888
900
911
894
900
947
1,016
1,072
1,159
1,163
1,186

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20184 days ago
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Integrated Filing (Financial)Feb 14, 2025
Standalone Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday February 14 2025 Pursuant To Regulation 30 Read With Schedule III(A)(IV) Of The SEBI (Listing Obligations And Disclosure RequiremeFeb 14, 2025
Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024 As Per Regulation 33 Of The SEBI (LODR) Regulations 2015Feb 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Closure of Trading WindowDec 27, 2024
Abnormal Price Rise Not Supported By Any Corporate Announcements Or Material Changes In The Business Activities & Manipulative Trade Observed & Request Urgent Attention For Possible MISUSE / UNETHICALDec 23, 2024
Price Of The Scrip Of Our Company Has Seen An Abnormal Price Rise, Which Was Not Supported By Any Corporate Announcements Or Material Changes In The Business Activities & Manipulative Trade Observed - Possible MISUSE / UNETHICAL / UNUSUAL TRADESDec 10, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 03, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 28, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 23, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations, 2015.Nov 14, 2024
Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024 As Per Regulation 33 Of The SEBI (LODR) Regulations, 2015Nov 07, 2024
Manipulative Trade Observed In Our Scrip And Request Urgent Attention For Possible MISUSE / UNETHICAL / UNUSUAL TRADES In Our Company Scrip, Which Is Not Supported By Any Corporate Announcements Or Material Changes In The Business Activities Of Our CompanyOct 25, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 24, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 03, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 29, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Closure of Trading WindowSep 25, 2024
Price Of The Scrip Of Our Company Has Seen An Abnormal Price Rise, Which Was Not Supported By Any Corporate Announcements Or Material Changes In The Business Activities Of Our Company And Manipulative Trade Observed In Our Scrip And Request Urgent Attention For Possible MISUSE / UNETHICAL / UNUSUAL TRADES In Our Company Scrip.Sep 11, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2024
Reg. 34 (1) Annual Report.Sep 03, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2024
Intimation Of 29Th Annual General Meeting (E-AGM) Of The Company, Cut-Off Date For Voting And E-Voting As Per Regulation 44 Of The SEBI (Listing Obligations And Disclosures Requirements [LODR]), Regulations, 2015Aug 16, 2024
Notice Of Book Closure As Per Regulation 42 Of The SEBI (Listing Obligations And Disclosures Requirements [LODR]), Regulations, 2015 For The Purpose Of 29Th Annual General Meeting (E-AGM) To Be Held On September 27, 2024.Aug 16, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 13, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2024
Standalone Un-Audited Financial Results For The Quarter Ended June 30, 2024Aug 12, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 12, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations, 2015.Aug 12, 2024
Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30, 2024 As Per Regulation 33 Of The SEBI (LODR) Regulations, 2015.Aug 03, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 02, 2024
Closure of Trading WindowJun 29, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportMay 31, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMay 31, 2024
Price Of The Scrip Of Our Company Has Seen An Abnormal Price Rise, Which Was Not Supported By Any Corporate Announcements Or Material Changes In The Business Activities Of Our Company And Manipulative Trade Observed In Our Scrip And Request Urgent Attention For Possible MISUSE / UNETHICAL / UNUSUAL TRADES In Our Company Scrip.May 30, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2024
Standalone Audited Financial Results For The Quarter And Year Ended March 31, 2024May 28, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 28, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations, 2015May 28, 2024
Board Meeting Intimation for Approval Standalone Audited Financial Results Along With Auditors Report For The Quarter And Year Ended On March 31, 2024 Pursuant To Regulation 33 Of SEBI (LODR) Regulations, 2015.May 20, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 02, 2024

Technical Indicators

RSI(14)
Neutral
64.43
ATR(14)
Volatile
10.98
STOCH(9,6)
Neutral
73.75
STOCH RSI(14)
Overbought
91.08
MACD(12,26)
Bullish
3.64
ADX(14)
Weak Trend
17.82
UO(9)
Bearish
61.63
ROC(12)
Uptrend And Accelerating
22.27
WillR(14)
Neutral
-22.60